In Healio Rheumatology: James O’Dell and Tuhina Neogi on the debate on gout treatment
From the February 25, 2022 issue of Healio Rheumatology
‘Horribly mismanaged’: Debate over gout treatment rages as cases surge
According to Tuhina Neogi, MD, PhD, professor of medicine and of epidemiology, Alan S. Cohen professor of rheumatology, and chief of rheumatology at the Boston University School of Medicine and Boston Medical Center, gout has been on the rise particularly in developed countries.
Tuhina Neogi
“The Global Burden of Disease Study provides some insights about what may be contributing to the doubling of the prevalence of gout in just under 30 years,” Neogi told Healio. “There has been a rise in the global population and increase in life expectancy over that time, but that alone is not sufficient to explain this dramatic increase in gout prevalence.”